Cargando…
Hsp70 in cancer: back to the future
Mechanistic studies from cell culture and animal models have revealed critical roles for the heat shock protein Hsp70 in cancer initiation and progression. Surprisingly, many effects of Hsp70 on cancer have not been related to its chaperone activity, but rather to its role(s) in regulating cell sign...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411196/ https://www.ncbi.nlm.nih.gov/pubmed/25347739 http://dx.doi.org/10.1038/onc.2014.349 |
_version_ | 1782368436823785472 |
---|---|
author | Sherman, Michael Y. Gabai, Vladimir L. |
author_facet | Sherman, Michael Y. Gabai, Vladimir L. |
author_sort | Sherman, Michael Y. |
collection | PubMed |
description | Mechanistic studies from cell culture and animal models have revealed critical roles for the heat shock protein Hsp70 in cancer initiation and progression. Surprisingly, many effects of Hsp70 on cancer have not been related to its chaperone activity, but rather to its role(s) in regulating cell signaling. A major factor that directs Hsp70 signaling activity appears to be the co-chaperone Bag3. Here, we review these recent breakthroughs, and how these discoveries drive drug development efforts. |
format | Online Article Text |
id | pubmed-4411196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-44111962016-02-06 Hsp70 in cancer: back to the future Sherman, Michael Y. Gabai, Vladimir L. Oncogene Article Mechanistic studies from cell culture and animal models have revealed critical roles for the heat shock protein Hsp70 in cancer initiation and progression. Surprisingly, many effects of Hsp70 on cancer have not been related to its chaperone activity, but rather to its role(s) in regulating cell signaling. A major factor that directs Hsp70 signaling activity appears to be the co-chaperone Bag3. Here, we review these recent breakthroughs, and how these discoveries drive drug development efforts. 2014-10-27 2015-08-06 /pmc/articles/PMC4411196/ /pubmed/25347739 http://dx.doi.org/10.1038/onc.2014.349 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Sherman, Michael Y. Gabai, Vladimir L. Hsp70 in cancer: back to the future |
title | Hsp70 in cancer: back to the future |
title_full | Hsp70 in cancer: back to the future |
title_fullStr | Hsp70 in cancer: back to the future |
title_full_unstemmed | Hsp70 in cancer: back to the future |
title_short | Hsp70 in cancer: back to the future |
title_sort | hsp70 in cancer: back to the future |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411196/ https://www.ncbi.nlm.nih.gov/pubmed/25347739 http://dx.doi.org/10.1038/onc.2014.349 |
work_keys_str_mv | AT shermanmichaely hsp70incancerbacktothefuture AT gabaivladimirl hsp70incancerbacktothefuture |